Industry News
Pharmaceutical Industry News
Excitement around Fujifilm…
Excitement around Fujifilm Biotechnologies’ massive new cell culture facility in Holly Springs, North Carolina, has been growing steadily since 2021, prompting a beefed-up investment from the company last April and a string of high-profile manufacturing
As drugmakers are turning away…
As drugmakers are turning away from England, Eli Lilly CEO David Ricks has joined the chorus, calling it “probably the worst country in Europe” for drug pricing and adding that England is “not an attractive environment
Indian generics makers have inked…
Indian generics makers have inked partnerships with the Gates Foundation, the Clinton Health Access Initiative and other groups to help roll out cheaper versions of Gilead's Yeztugo in certain low- and middle-income countries.
Hengrui Pharma’s dealmaking…
Hengrui Pharma’s dealmaking spree rolls on, with a potential $1.1 billion transaction on a rival to AstraZeneca and Daiichi Sankyo’s blockbuster Enhertu being the latest addition.
The FDA has handed Biogen a…
The FDA has handed Biogen a complete response letter requesting that the company update “technical information” included in the chemistry, manufacturing and controls portion of its filing for high-dose Spinraza. Biogen said it aims to
The Billionaire, the Psychedelics and the Best-Selling Memoir
Amy Griffin wrote a book based on recovered memories of childhood sexual abuse. Oprah Winfrey and a slew of celebrities promoted it. Then questions arose.
Vertex has begun a full-court…
Vertex has begun a full-court press for Journavx, enlisting NBA All-Star Jayson Tatum to discuss his use of the new non-opioid painkiller while recovering from a serious injury.
F.D.A.’s Approval of a Drug for Autism Upends Review Process
The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers scrambling to buy over-the-counter supplements with the same ingredients.
Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuits
The Trump administration has cited Dr. Andrea Baccarelli’s expertise to warn against using acetaminophen — the active ingredient in Tylenol — in pregnancy, based on an unproven autism link.
4 Autism Experts React to Trump’s Plan
This is not what people with autism need, experts say.
Although more than half of Gen Z…
Although more than half of Gen Z survey respondents turn to doctors and experts for health advice, 38% also value social media as a trusted source, compared to 22% among other, older generations.
In a recent warning letter, the…
In a recent warning letter, the FDA chastised Janssen Vaccines for inconsistent quality control procedures and failure to follow up thoroughly on product complaints—issues that came to light during an inspection of the Johnson &
Public health experts and doctors…
Public health experts and doctors say the ACIP's chaotic voting process and changes to vaccine recommendations will sow confusion and doubt among patients and parents.
PatientView surveyed a total of…
PatientView surveyed a total of 518 patient groups representing dozens of rare diseases. Their responses detail their views of 32 pharmas and the industry at large in 2024.
Moderna has early in-human data…
Moderna has early in-human data showing its next-generation COVID-19 vaccine, mNEXSPIKE, has the potential to offer strong immune protection against the latest rapidly spreading SARS-CoV-2 virus variant.
Celltrion—which specializes in…
Celltrion—which specializes in biosimilar drugs—has inked an agreement to purchase Eli Lilly’s drug substance plant in Branchburg, New Jersey, for 460 billion Korean won ($330 million), according to a Sept. 23 shareholder letter. The deal
Scholar Rock’s bid to win the…
Scholar Rock’s bid to win the first FDA approval for a muscle-targeted treatment for spinal muscular atrophy has been tripped up by inspection issues at a former Catalent production site in Indiana, now owned by
Catalent cut the ribbon on its new…
Catalent cut the ribbon on its new global corporate headquarters in Florida as the CDMO giant nears the anniversary of its sale to Novo Nordisk.
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
La empresa detrás de Tylenol intenta sortear su crisis más reciente
Kenvue, una empresa derivada de Johnson & Johnson, se enfrenta a una pesadilla de relaciones públicas ya que el presidente Trump y otros sugieren vínculos no probados entre el analgésico y el autismo.